Temple, TX, United States of America

Joo Youn Oh


 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Temple, TX (US) (2014 - 2015)
  • Seoul, KR (2017 - 2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of Joo Youn Oh

Introduction

Joo Youn Oh is a notable inventor based in Temple, Texas, who has made significant contributions to the field of ocular treatment through his innovative research and patents. With a total of five patents to his name, he has focused on developing methods and compositions that utilize adult stem cells and progenitor cells for the treatment of eye injuries and diseases.

Latest Patents

One of Joo Youn Oh's latest patents involves the use of adult stem cells and stem cell proteins for treating ocular diseases, disorders, or conditions in mammals. This invention encompasses a population of mesenchymal stromal cells that exhibit anti-inflammatory, anti-apoptotic, immune modulatory, and anti-tumorigenic properties. The patent details the administration of TSG-6, STC-1, or a combination thereof as a treatment for various ocular conditions.

Career Highlights

Throughout his career, Joo Youn Oh has worked with esteemed organizations such as the Texas A&M University System and Temple Therapeutics, Inc. His work has been instrumental in advancing the understanding and treatment of ocular diseases, showcasing his commitment to innovation in the medical field.

Collaborations

Joo Youn Oh has collaborated with notable colleagues, including Darwin J. Prockop and Barry A. Berkowitz, further enhancing the impact of his research and inventions.

Conclusion

Joo Youn Oh's contributions to ocular treatment through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical treatments for eye injuries and diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…